DOCSLIB.ORG

Differential Gene and Protein Expression in Pig Nuclear Transfer Extraembryonic Membranes and Blastocyst Stage Embryos

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Differential Gene and Protein Expression in Pig Nuclear Transfer Extraembryonic Membranes and Blastocyst Stage Embryos DIFFERENTIAL GENE AND PROTEIN EXPRESSION IN PIG NUCLEAR TRANSFER EXTRAEMBRYONIC MEMBRANES AND BLASTOCYST STAGE EMBRYOS A Dissertation presented to the Faculty of the Graduate School University of Missouri In Partial Fulfillment Of the Requirement for the Degree Doctorate of Philosophy by KRISTIN MARIE WHITWORTH Dr. RANDALL S. PRATHER, Dissertation Supervisor DECEMBER 2010 The undersigned, appointed by the Dean of the Graduate School, have examined the dissertation entitled GENE AND PROTEIN EXPRESSION IN PIG NUCLEAR TRANSFER EXTRAEMBRYONIC MEMBRANES AND BLASTOCYST STAGE EMBRYOS Presented by Kristin M. Whitworth A candidate for the degree of Doctor of Philosophy And hereby certify that in their opinion it is worth of acceptance. Professor Randall S. Prather Professor Rodney D. Geisert Professor Peter Sutovsky Professor R. Michael Roberts Professor Yuksel Agca ACKNOWLEDEMENTS I would like to thank the members of my committee Dr. Randall Prather, Dr. Peter Sutovsky, Dr. Rodney Geisert, Dr. R. Michael Roberts and Dr. Yuksel Agca for all of their guidance and suggestions throughout my PhD program. I couldn‟t have asked for a better committee, always prompt and helpful. My advisor, Dr. Prather has been so patient with me as I have worked through this degree and I appreciate this so much. There are also so many members of the Prather lab that I would like to thank. This project involved collection of samples from over 150 pigs and Lee Spate assisted with every pig. His help and friendship will always be appreciated along with August Rieke who was always by our side. Thank you Dr. Clifton Murphy for performing all the embryo transfers needed to complete this project and for helping me appreciate our country and those who have sacrificed for it. Thank you for all the close friendships that have been developed while working in the lab. A fun job with great people has made this process so enjoyable. Thank you Jason Ross, Clay Isom, Jeff Whyte, Melissa Samuel, Bethany Bauer, Eric Walters, Kyle Dobbs, Mingtao Zhao, Jiude Mao, Jennifer Teson and Lisa Tracy, I have enjoyed working with all of you. I‟d also like to thank Jianguo Zhao for all of his advice and help with the Scriptaid experiments. Thank you to Dr. Peter Sutovsky and his lab members Miriam Sutovsky and Gauri Manandhar for helping with this project. The microscopy work from from Gauri and Miriam greatly aided in the publication of Chapter 2. Also thank ii you for the help of Dr. Jonathan Green‟s lab and his senior research specialist, Tina Egen. Their help with Western Blotting, Immunohistochemistry and expertise in placental biology was greatly appreciated. I would also like to thank my supportive family. My husband Jon spent many evenings and weekends caring for our children, Erin, Jordan and Kathleen, so that I could study and write. I couldn‟t have done it without him. My parents, Bill and Kathy Whitworth, have spent the last four years taking care of the kiddos during Christmas and summers breaks so that I wouldn‟t have to take time off from my project. Thank you Jon, thank you Mom and Dad and thank you kids for being patient. I hope that the three of you will grow up to value education. Lastly I would like to thank my friends that continued their education “later in life” and inspired me to do the same. iii TABLE OF CONTENTS AKNOWELEDGEMENTS……………………………………………………………………….ii LIST OF FIGURES………………………………………………………………………………x LIST OF TABLES………………………………………………………………………………xiii NOMENCLATURE……………………………………………………………………………..xv ABSTRACT…………………………………………………………………………………….xvii Chapter 1. REVIEW OF LITERATURE…………………………………………………………….1 Introduction……………………………………………………………………………....1 Brief History of Nuclear Transfer in Animals………………………………………....2 The Role of Enhanced Green Fluorescent Protein (EGFP) in NT Pigs…………...4 Nuclear Transfer and Genetically Modified Pigs for Use in Agriculture….….…….6 Nuclear Transfer and Genetically Modified Pigs for Use as Human Disease Models……………………………………………………………….8 Nuclear Transfer and its Effects on Placentation…………………………………..13 Pig………………………………………………………………………………13 Mouse………………………………………………………………………….14 Cow…………………………………………………………………………….18 Why is important to study porcine placentation and nuclear transfer?.....19 Nuclear Reprogramming…………………………………………………………...…20 Fusion and Activation After Nuclear Transfer………………………………………21 Oocyte Activation……………………………………………………………..21 Activation and Fusion of NT Zygotes……………………………………….22 Effects of Nuclear Transfer on Gene Expression…………………………………..23 iv Pig………………………………………………………………………………25 Cow……………………………………………………………………………..29 Histone Deacetylase Inhibitors and How They Improve Nuclear Transfer………32 Histone Deacetylation and Acetylation……………………………………..32 Description of the Histone Deacetylase Inhibitor, Scriptaid………………34 Using HDACi to Improve Nuclear Transfer……………….……………………...…36 Pig………………………………………………………………………………36 Cow……………………………………………………………………………..39 Mouse…………………………………………………………………………..41 Other Methods to Improve Nuclear Transfer……………………………………….45 Altering DNA Methylation…………………………………………………….45 Inhibition of Proteasomal Machinery………………………………………..45 Conclusions…………………………………………………………………………….47 2. Method of Oocyte Activation Affects Cloning Efficiency in Pig……………………50 Abstract...……………………………………………………………………………….50 Introduction……………………………………………………………………………..52 Materials and Methods………………………………………………………………..55 Animal Use………………………………………………………………….…55 Chemicals……………………………………………………………………...55 Preparation of pCAGG-EGFP Construct………………………………...…55 Preparation of Donor Cells…………………………………………………..56 Transfection of Donor Cells with pCAGG-EGFP………………………….57 Preparation of Recipient Oocytes and NT…………………………………57 Fusion and Activation of the Oocyte and Donor Cell……………………..58 Embryo Transfer and Embryo Collection…………………………………..59 v Pregnancy Rates and Recovery Rates……………………………………..60 Nuclei Count in Blastocyst-stage Embryos………………………………...61 Immunofluorescence………………………………………………………….61 Results………………………………………………………………………….………61 Fusion Rates…………………………………………………………………..61 Donor Cell Nuclear Remodeling…………………………………………….62 Mean Number of Nuclei per Blastocyst…………………………………….63 Pregnancy Rates and Recovery Rates…………………………………….63 Birth of pCAGG-EGFP Positive Piglets…………………………………….65 Discussion………………………………………………………………………………65 Conclusions…………………………………………………………………………….69 Acknowledgements……………………………………………………………………69 3. Activation Method Does Not Alter Abnormal Gene Expression and Development in Cloned Pigs…………………………………………………………78 Abstract…………………………………………………………………………………78 Introduction……………………………………………………………………………..80 Materials and Methods………………………………………………………………..83 Ethical Guidelines……………………………………………………………..83 MIAME Compliance…………………………………………………………..84 Chemicals……………………………………………………………………...84 Animals, Donor Cell Line and Oocytes……………………………………..84 Embryo Transfer………………………………………………………………86 Sample Collection for Microarray, Real-time PCR and Western Blotting Analysis………………………………………………86 vi RNA Isolation and cDNA Synthesis…………………………………………87 Sex Determination of Extraembryonic Membranes……………………….87 Microarray Reference Design Experiment…………………………………88 Microarray Analysis by Genespring 7.3.1………………………………….89 Database for Annotation, Visualization and Integrated Discovery (DAVID)…………………………………………………………………....…..90 Real-time PCR Validation……………………………………………………91 Western Blotting and Densitometry…………………………………………92 Measurement of Acid Peptidase Activity (APA)……………………………94 Immunohistochemistry…………………………………………………….….94 Image Acquisition ……………………………………………………….……96 Results………………………………………………………………………………….97 Supplemental Files……………………………………………………………97 Pregnancy Rates……………………………………………………………...97 Sex Determinations of Extraembryonic Membranes……………………...98 Labeling Efficiency……………………………………………………………98 Microarray Comparisons……………………………………………………..98 Database for Annotation, Visualization and Integrated Discovery (DAVID)……………………………………………………………………….100 Real-Time PCR Validation………………………………………………….100 Western Blotting and Densitometry………………………………………..101 Acid Peptidase Activity……………………………………………………...102 Immunohistochemisty……………………………………………………….102 Discussion…………………………………………………………………………….104 Conclusion…………………………………………………………………………….110 vii Acknowledgements…………………………………………………………………..110 4. Scriptaid Corrects Gene Expression of Several Aberrantly Reprogrammed Transcripts in Nuclear Transfer Pig Blastocyst Stage Embryos………………...118 Abstract………………………………………………………………………………..118 Introduction……………………………………………………………………………120 Materials and Methods………………………………………………………………123 Supplemental Files………………………………………………………….123 Ethical Guidelines……………………………………………………………124 MIAME Compliance…………………………………………………………124 Chemicals…………………………………………………………………….124 Animals, Donor Cell Line and Oocytes……………………………………124 Treatment Group Description: BLIVV, BLIVF, NT1, NT2, NT3, NTS…125 Embryo Transfer……………………………………………………………..126 Nuclear Protein Extraction and HDAC Assay…………………………….127 Quantification of Global Methylation in NT Embryos…………………….127 Sample Collection for Microarray and Real-time PCR…………………..128 RNA Isolation and cDNA Synthesis of the Reference Sample………....129 RNA Isolation and Amplification of the Embryo and Cells………………130 Microarray Reference Design Experiment………………………………..130 Labeling Efficiency…………………………………………………………..131 Microarray Analysis by Genespring 7.3.1…………………………………131 Identification of Aberrantly Reprogrammed Transcripts…………………132 Resequencing of ESTs from the 5′ Direction……………………………..133 Database for Annotation, Visualization and Integrated Discovery (DAVID)……………………………………………………………………….133 viii Real-time
Load more

Recommended publications
  • Eosin Y Catalysed Photoredox Synthesis: a Review
    RSC Advances REVIEW View Article Online View Journal | View Issue Eosin Y catalysed photoredox synthesis: a review a b Cite this: RSC Adv.,2017,7,31377 Vishal Srivastava and Praveen P. Singh * In recent years, photoredox catalysis using eosin Y has come to the fore front in organic chemistry as a powerful strategy for the activation of small molecules. In a general sense, these approaches rely on the ability of organic dyes to convert visible light into chemical energy by engaging in single-electron Received 14th May 2017 transfer with organic substrates, thereby generating reactive intermediates. In this perspective, we Accepted 13th June 2017 highlight the unique ability of photoredox catalysis to expedite the development of completely new DOI: 10.1039/c7ra05444k reaction mechanisms, with particular emphasis placed on multicatalytic strategies that enable the rsc.li/rsc-advances construction of challenging carbon–carbon and carbon–heteroatom bonds. 1. Introduction However, the transition metal based photocatalysts disadvantageously exhibit high cost, low sustainability and Visible light photoredox catalysis has recently received much potential toxicity. Recently, a superior alternative to transition Creative Commons Attribution 3.0 Unported Licence. attention in organic synthesis owing to ready availability, metal photoredox catalysts, especially metal-free organic dyes sustainability, non-toxicity and ease of handling of visible particularly eosin Y has been used as economically and 1–13 light but the general interest in the eld started much ecologically superior surrogates for Ru(II)andIr(II)complexes earlier.14 Unlike thermal reactions, photoredox processes occur in visible-light promoted organic transformations involving 18–21 under mild conditions and do not require radical initiators or SET (single electron transfer).
    [Show full text]
  • Upregulation of Peroxisome Proliferator-Activated Receptor-Α And
    Upregulation of peroxisome proliferator-activated receptor-α and the lipid metabolism pathway promotes carcinogenesis of ampullary cancer Chih-Yang Wang, Ying-Jui Chao, Yi-Ling Chen, Tzu-Wen Wang, Nam Nhut Phan, Hui-Ping Hsu, Yan-Shen Shan, Ming-Derg Lai 1 Supplementary Table 1. Demographics and clinical outcomes of five patients with ampullary cancer Time of Tumor Time to Age Differentia survival/ Sex Staging size Morphology Recurrence recurrence Condition (years) tion expired (cm) (months) (months) T2N0, 51 F 211 Polypoid Unknown No -- Survived 193 stage Ib T2N0, 2.41.5 58 F Mixed Good Yes 14 Expired 17 stage Ib 0.6 T3N0, 4.53.5 68 M Polypoid Good No -- Survived 162 stage IIA 1.2 T3N0, 66 M 110.8 Ulcerative Good Yes 64 Expired 227 stage IIA T3N0, 60 M 21.81 Mixed Moderate Yes 5.6 Expired 16.7 stage IIA 2 Supplementary Table 2. Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis of an ampullary cancer microarray using the Database for Annotation, Visualization and Integrated Discovery (DAVID). This table contains only pathways with p values that ranged 0.0001~0.05. KEGG Pathway p value Genes Pentose and 1.50E-04 UGT1A6, CRYL1, UGT1A8, AKR1B1, UGT2B11, UGT2A3, glucuronate UGT2B10, UGT2B7, XYLB interconversions Drug metabolism 1.63E-04 CYP3A4, XDH, UGT1A6, CYP3A5, CES2, CYP3A7, UGT1A8, NAT2, UGT2B11, DPYD, UGT2A3, UGT2B10, UGT2B7 Maturity-onset 2.43E-04 HNF1A, HNF4A, SLC2A2, PKLR, NEUROD1, HNF4G, diabetes of the PDX1, NR5A2, NKX2-2 young Starch and sucrose 6.03E-04 GBA3, UGT1A6, G6PC, UGT1A8, ENPP3, MGAM, SI, metabolism
    [Show full text]
  • (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 De Juan Et Al
    US 200601 10428A1 (19) United States (12) Patent Application Publication (10) Pub. No.: US 2006/0110428A1 de Juan et al. (43) Pub. Date: May 25, 2006 (54) METHODS AND DEVICES FOR THE Publication Classification TREATMENT OF OCULAR CONDITIONS (51) Int. Cl. (76) Inventors: Eugene de Juan, LaCanada, CA (US); A6F 2/00 (2006.01) Signe E. Varner, Los Angeles, CA (52) U.S. Cl. .............................................................. 424/427 (US); Laurie R. Lawin, New Brighton, MN (US) (57) ABSTRACT Correspondence Address: Featured is a method for instilling one or more bioactive SCOTT PRIBNOW agents into ocular tissue within an eye of a patient for the Kagan Binder, PLLC treatment of an ocular condition, the method comprising Suite 200 concurrently using at least two of the following bioactive 221 Main Street North agent delivery methods (A)-(C): Stillwater, MN 55082 (US) (A) implanting a Sustained release delivery device com (21) Appl. No.: 11/175,850 prising one or more bioactive agents in a posterior region of the eye so that it delivers the one or more (22) Filed: Jul. 5, 2005 bioactive agents into the vitreous humor of the eye; (B) instilling (e.g., injecting or implanting) one or more Related U.S. Application Data bioactive agents Subretinally; and (60) Provisional application No. 60/585,236, filed on Jul. (C) instilling (e.g., injecting or delivering by ocular ion 2, 2004. Provisional application No. 60/669,701, filed tophoresis) one or more bioactive agents into the Vit on Apr. 8, 2005. reous humor of the eye. Patent Application Publication May 25, 2006 Sheet 1 of 22 US 2006/0110428A1 R 2 2 C.6 Fig.
    [Show full text]
  • Hematoxylin and Eosin Stain (H&E)
    Hematoxylin and Eosin Stain (H&E) TECHNIQUE: Formalin fixed, paraffin tissue sections REAGENTS: Mayer’s Hematoxylin (Source Medical, catalog# 9235360) 0.5% Acid Alcohol 70% Ethanol ----------------------------------------------------------------------995ml Hydrochloric Acid, (36.5% - 38%) ------------------------------------------- 5ml 1X PBS (pH 7.2-7.3) Alcoholic-Eosin 1.0% Eosin Y Eosin Y (CAS# 17372-87-1) -------------------------------------------------- 1.0 g Distilled water ------------------------------------------------------------------ 100 ml 1.0% Phloxine B Phloxine B (CAS# 18472-87-2) ---------------------------------------------- 0.5 g Distilled water ------------------------------------------------------------------ 50.0 ml Working Alcoholic-Eosin Solution 1.0% Eosin Y ------------------------------------------------------------------- 50.0 ml 1.0% Phloxine B --------------------------------------------------------------- 5.0 ml 95% Ethanol -------------------------------------------------------------------- 390.0 ml Acetic acid, glacial ------------------------------------------------------------- 4.0 ml 11/2018 Hematoxylin and Eosin Stain (H&E) 5 micron Paraffin Sections PROCEDURE: 1. Deparaffinize and rehydrate slides to distilled water 2. Stain in Mayers Hematoxylin for 1 minute 3. Wash with 4-5 changes of Tap water or until blue stops coming off slides 4. Blue nuclei in 1X PBS for 1 minute 5. Wash with 3 changes of distilled water 6. Counterstain in Alcoholic-Eosin for 1 minute (DO NOT RINSE) 7. Dehydrate through 3
    [Show full text]
  • Outcomes of Conservative Treatment of Giant Omphaloceles with Dissodic 2% Aqueous Eosin: 15 Years' Experience
    Access this article online Website: Original Article www.afrjpaedsurg.org DOI: 10.4103/0189-6725.132825 PMID: *** Outcomes of conservative treatment of giant Quick Response Code: omphaloceles with dissodic 2% aqueous eosin: 15 years’ experience B. D. Kouame, T. H. Odehouri Koudou, J. B. Yaokreh, M. Sounkere, S. Tembely, K. G. S. Yapo, R. Boka, M. Koffi, A. G. Dieth, O. Ouattara, A. da Silva, R. Dick INTRODUCTION ABSTRACT Background: The surgical management of giant Surgical treatment of the giant omphaloceles leads to omphalocele is a surgical challenge with high several haemodynamic and respiratory complications mortality and morbidity in our country due to the which increase their mortality. To reduce the morbidity absence of neonatal resuscitation. This study evaluates conservative management of giant and the mortality of the surgical management of the giant omphalocele with dissodic 2% aqueous eosin. omphalocele, conservative’s treatments with antiseptic Materials and Methods: In the period from January solutions were carried out.[1-3] Povidone iodine and 1997 to December 2012, giant omphaloceles were merbromin have been used during several years due to their treated with dissodic 2% aqueous eosin. The capacity to promote escharification and epithelialization procedure consisted of twice a day application of of the omphalocele sac. However due to complications dissodic 2% aqueous eosin (sterile solution for topical application) on the omphalocele sac. The such as transient hypothyroidism with povidone iodine or procedure was taught to the mother to continue mercury poising with merbromin, there was the cessation at home with an outpatient follow-up to assess of their use for conservative treatment.[1-4] epithelialization.
    [Show full text]
  • Eosin Staining
    Science of H & E Andrew Lisowski, M.S., HTL (A.S.C.P.) 1 Hematoxylin and Eosin Staining “The desired end result of a tissue stained with hematoxylin and eosin is based upon what seems to be almost infinite factors. Pathologists have individual preferences for section thickness, intensities, and shades. The choice of which reagents to use must take into consideration: cost, method of staining, option of purchasing commercially-prepared or technician-prepared reagents, safety, administration policies, convenience, availability, quality, technical limitations, as well as personal preference.” Guidelines for Hematoxylin and Eosin Staining National Society for Histotechnology 2 Why Do We Stain? In order to deliver a medical diagnosis, tissues must be examined under a microscope. Once a tissue specimen has been processed by a histology lab and transferred onto a glass slide, it needs to be appropriately stained for microscopic evaluation. This is because unstained tissue lacks contrast: when viewed under the microscope, everything appears in uniform dull grey color. Unstained tissue H&E stained tissue 3 What Does "Staining" Do? . Contrasts different cells . Highlights particular features of interest . Illustrates different cell structures . Detects infiltrations or deposits in the tissue . Detect pathogens Superbly contrasted GI cells Placenta’s large blood H&E stain showing extensive vessels iron deposits There are different staining techniques to reveal different structures of the cell 4 What is H&E Staining? As its name suggests, H&E stain makes use of a combination of two dyes – hematoxylin and eosin. It is often termed as “routine staining” as it is the most common way of coloring otherwise transparent tissue specimen.
    [Show full text]
  • Photophysical and Antibacterial Activity of Light- Activated Quaternary Eosin Y
    Open Chem., 2019; 17: 1244–1251 Research Article Desislava Staneva, Stanislava Yordanova*, Evgenia Vasileva-Tonkova, Stanimir Stoyanov, Ivo Grabchev Photophysical and antibacterial activity of light- activated quaternary eosin Y https://doi.org/10.1515/chem-2019-0135 received December 3, 2018; accepted May 9, 2019. Keywords: eosin Y, photophysics, antimicrobial activity, antibacterial textile Abstract: The functional characteristics of a new eosin dye with biocidal quaternary ammonium group (E) were studied in aqueous solution and in organic solvents of 1 Introduction different polarity. The spectral properties depend on the nature and polarity of the respective solvents. The Fluorescent compounds are often used in medicine, antimicrobial activity of compound E has been tested in pharmacy, biology and environmental protection [1,2]. vitro against Gram-negative bacteria (Escherichia coli, Among the known fluorophore structures used in these Acinetobacter johnsoni and Pseudomonas aeruginosa), fields, the eosin Y and its derivatives are very important. Gram-positive bacteria (Sarcina lutea and Bacillus cereus) They belong to the group of xanthene fluorescent dyes and the antifungal activity was tested against the yeasts with a wide range of photophysical and biological Candida lipolytica in solution and after treated on cotton applications, due to their low toxicity in vivo, and high fabric. Broth dilution test has been used for quantitative water solubility [3]. The utility of eosin derivatives is evaluation of the antimicrobial activity of compound E associated to their good spectral characteristics and the against the model strains. The ability of compound E to possibility to interact with different type of biomolecules inhibit the growth of model Gram-negative P.
    [Show full text]
  • 2011/058582 Al O
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date i 1 m 19 May 2011 (19.05.2011) 2011/058582 Al (51) International Patent Classification: Road, Sholinganallur, Chennai 600 119 (IN). CHEN- C07C 259/06 (2006.01) A61P 31/00 (2006.01) NIAPPAN, Vinoth Kumar [IN/IN]; Orchid Research C07D 277/46 (2006.01) A61K 31/426 (2006.01) Laboratories Ltd., R & D Centre: Plot No: 476/14, Old C07D 277/48 (2006.01) A61K 31/55 (2006.01) Mahabalipuram Road, Sholinganallur, Chennai 600 119 C07D 487/08 (2006.01) (IN). GANESAN, Karthikeyan [IN/IN]; Orchid Re search Laboratories Ltd., R & D Centre: Plot No: 476/14, (21) International Application Number: Old Mahabalipuram Road, Sholinganallur, Chennai 600 PCT/IN20 10/000738 119 (IN). NARAYANAN, Shridhar [IN/IN]; Orchid Re (22) International Filing Date: search Laboratories Ltd., R & D Centre: Plot No: 476/14, 12 November 2010 (12.1 1.2010) Old Mahabalipuram Road, Sholinganallur, Chennai 600 119 (IN). (25) Filing Language: English (74) Agent: UDAYAMPALAYAM PALANISAMY, (26) Publication Language: English Senthilkumar; Orchid Chemicals & Pharmaceuticals (30) Priority Data: LTD., R & D Centre: Plot No: 476/14, Old Mahabalipu 2810/CHE/2009 16 November 2009 (16. 11.2009) IN ram Road, Sholinganallur, Chennai 600 119 (IN). (71) Applicant (for all designated States except US): OR¬ (81) Designated States (unless otherwise indicated, for every CHID RESEARCH LABORATORIES LTD. [IN/IN]; kind of national protection available): AE, AG, AL, AM, Orchid Towers, 313, Valluvar Kottam High Road, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, Nungambakkam, Chennai 600 034 (IN).
    [Show full text]
  • Basics of Hematology and Patho-Histology
    Basics of Hematology and Patho-histology Practical Course in Molecular Pathology Winter Term 2015 Ernst Müllner MFPL (Max F Perutz Laboratories) Department of Medical Biochemistry Medical University of Vienna [email protected] www.mfpl.ac.at/mfpl-group/group/muellner.html (Müllner homepage / research) E. coli + macrophages medicalschool.tumblr.com/post/43914024728/sem-image-of-e-coli-bacteria-and-macrophages medicalschool.tumblr.com/post/18256087351/r ed-blood-cells-erythrocytes-trapped-by-fibrin Overview on main white blood cell (WBC) types – (Wikipedia) Mature white blood cell types I White Blood cells (WBCs) are frequently also referred to as peripheral blood mononuclear cells (PBMCs). Granulocytes in general are part of the innate immune system. Names derive from staining with hematoxylin and eosin. Whereas basophils stain dark blue and eosinophils are bright red, neutrophils stain neutral to pink. Basophil granulocytes Eosinophil granulocytes Neutrophil granulocytes Least common granulocyte type About 1-6% of WBCs; component Most abundant WBC type (40- (0.01- 0.3% of WBCs. Large of innate immune system to com- 75%) and essential part of the cytoplasmic granules obscure the bat parasites and certain infec- innate immune system. A patho- nucleus under the microscope. tions; also associated with allergy gen is likely to first encounter a When unstained, the nucleus is and asthma. Following activation, neutrophil. Normally contain a nu- visible and usually has 2 lobes. eosinophils effector functions in- cleus of 2-5 lobes. Neutrophils Basophils appear in inflammatory clude production and release (de- quickly congregate at a infection reactions, particularly those granulation) of cytotoxic substan- site, attracted by cytokines from causing allergies, mainly via the ces (granule proteins, reactive activated endothelium, mast cells, vasodilator histamine (antihistami- oxygen species …) and production or macrophages.
    [Show full text]
  • Hematoxylin & Eosin
    Washington University School of Medicine Neuromuscular Lab CAP: 1923316 CLIA: 26D0652044 NY: PFI 3499 HEMATOXYLIN & EOSIN (H & E) STAIN PROTOCOL PRINCIPLE: This protocol is applied in the routine staining of cationic and anionic tissue components in tissue sections. This is the standard reference stain used in the study of histochemical tissue pathology. SPECIMEN REQUIRED: Snap frozen human striated muscle. (Use the 2-methylbutane freezing method) METHOD: Fixation: None. Use snap frozen tissue. Technique: Cut 10 - 16 micron (12 µm) sections in cryostat from snap frozen biopsy. Attach first and last sections to a Superfrost Plus microscope slide. Equipment: Ceramic staining rack - Thomas Scientific #8542-E40 Columbia staining dish - Thomas Scientific #8542-C12 Columbia staining dish(jar) - Thomas Scientific #8542-E30 Forceps Latex gloves Reagents: Reagent alcohol - HPLC Fisher A995-4 or histological A962, FLAMMABLE store at room temp. in a flammable cabinet Eosin Y, disodium salt (Sigma #E-6003, store at room temperature) Harris Hematoxylin Stain, acidified (Lerner Laboratories #1931382)(R.T.) Permount - Fisher SP15-100, FLAMMABLE; HEALTH HAZARD Xylenes (Fisher #HC700-1GAL, FLAMMABLE Solutions: I. Eosin Y, 1 % aqueous (store at room temperature) Eosin Y dye 1 g Deionized water 100 ml H&E protocol.docx 1997 Washington University School of Medicine Neuromuscular Lab CAP: 1923316 CLIA: 26D0652044 NY: PFI 3499 2. Harris Hematoxylin, acidified (store at room temperature) Filter (Baxter #F2217-150, Grade 363, Qualitative) before use 3. Alcohol 50 % reagent alcohol ~50 ml deionized water ~50 ml 4. Alcohol 70 % reagent alcohol ~70 ml deionized water ~30 ml 5. Alcohol 80 % reagent alcohol ~80 ml deionized water ~20 ml 6.
    [Show full text]
  • Microspore Embryogenesis: Targeting the Determinant Factors of Stress- Induced Cell Reprogramming for Crop Improvement
    1 2 3 4 Microspore embryogenesis: targeting the determinant factors of stress- 5 induced cell reprogramming for crop improvement 6 7 8 Pilar S. Testillano 9 10 Pollen Biotechnolgy of Crop Plants group. Biological Research Center, CIB-CSIC. 11 Ramiro de Maeztu 9, 28040 Madrid. Spain 12 E-mail: [email protected] 13 Phone: +34-918373112 (Ext: 4366) 14 15 Date of submission: October 31, 2018 16 Number of figures: 5. 17 Word count: 6312. 18 19 Running title: 20 Determinant factors of stress-induced microspore embryogenesis in crops 1 21 ABSTRACT 22 23 Under stress, isolated microspores are reprogrammed in vitro towards embryogenesis, 24 producing doubled haploid plants, useful biotechnological tools in plant breeding as a 25 source of new genetic variability, fixed in homozygous plants in only one generation. 26 Stress-induced cell death and low rates of cell reprogramming are major factors that 27 reduce the process yield. Knowledge gained in recent years has revealed that 28 microspore embryogenesis initiation and progression involve a complex network of 29 factors, whose roles are not yet well understood. Autophagy and cell-death proteases are 30 crucial players in the response to stress, while cell reprogramming and totipotency 31 acquisition are regulated by hormonal and epigenetic mechanisms. Auxin biosynthesis, 32 transport and action are required for microspore embryogenesis. Initial stages involve 33 DNA hypomethylation, H3K9 demethylation, and H3/H4 acetylation. Cell wall 34 remodelling, with pectin de-methylesterification and AGP expression, is necessary for 35 embryo development. We will review recent findings regarding the determinant factors 36 underlying stress-induced microspore embryogenesis, focusing on the role of 37 autophagy, cell death, auxin, chromatin modifications, and cell wall.
    [Show full text]
  • Epigenetic Malleability at Core Promoter Regulates Tobacco PR-1A
    bioRxiv preprint doi: https://doi.org/10.1101/2021.07.24.453639; this version posted July 25, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 1 Research article: 2 Epigenetic Malleability at Core Promoter Regulates Tobacco PR-1a 3 Expression after Salicylic Acid Treatment 4 5 Authors: Niraj Lodhi1*, Mala Singh1, Rakesh Srivastava1, Samir V. Sawant1, and Rakesh 6 Tuli1,3 7 8 1. National Botanical Research Institute, Council of Scientific and Industrial Research, Rana 9 Pratap Marg, Lucknow-226001, India 10 2. Present address: University Institute of Engineering & Technology (UIET), Sector 25, 11 Panjab University, Chandigarh 160014, India 12 13 14 *Corresponding Author: 15 Niraj Lodhi, Ph.D. 16 Lead, Clinical Research (Research and Development Division) 17 Genesis DiaGnostics 18 LanGhorne, PA 19047 19 Ph: 267-212-2000 Ext. 156 20 Fax: 267-212-2005 21 E-mail: [email protected] 22 23 24 25 SUMMARY 26 Histone methylation and acetylation regulation of tobacco PR-1a promoter are significant for 27 disassembly of the nucleosome and repressor proteins during induction. 28 1 bioRxiv preprint doi: https://doi.org/10.1101/2021.07.24.453639; this version posted July 25, 2021. The copyright holder for this preprint (which was not certified by peer review) is the author/funder. All rights reserved. No reuse allowed without permission. 29 ABSTRACT 30 • Tobacco’s PR-1a gene is induced by pathogen attack or exogenous application of 31 Salicylic Acid (SA). However, the epigenetic modifications of the most important 32 inducible promoter of the PR-1a gene are not understood clearly.
    [Show full text]